2026 NPPES data Hematology & Oncology Physician NPI 1043839012 DO
Verify on CMS →

Travis Brachtenbach, DO

Hematology & Oncology Physician in Galveston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
288
Medicare Part D claims · 39 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
0%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Travis Brachtenbach, DO filed 288 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Galveston, Texas, prescribing 0% generic.

288
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Travis Brachtenbach, DO's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

288 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Travis Brachtenbach, DO practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Travis Brachtenbach, DO?

Quality data not reported

NPI registry status

Active

Issued 04/10/2020

NPI 1043839012

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

288 66% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Hematology & Oncology Physician - 0.1%Hematology & Oncology Physician0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Travis Brachtenbach, DO appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding DO credentials at 301 UNIVERSITY BLVD, Galveston, TX, 77555, with a listed phone of (832) 505-1910. NPI 1043839012 was issued on 04/10/2020.

Medicare Part D records for calendar year 2023 show 288 prescription claims written by this provider, covering 39 Medicare beneficiaries and totaling roughly $391K in drug spend, split 50% brand-name and 0% generic by claim count.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

301 UNIVERSITY BLVD
Galveston, TX 77555

Provider Details

NPI 1043839012
Specialty Hematology & Oncology Physician
Credentials DO
Gender Male
NPI Issued 04/10/2020

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Travis Brachtenbach, DO. To verify Travis Brachtenbach, DO's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Travis Brachtenbach, DO - brand share 50.0%
Hematology & Oncology Physician average

50% brand-name claims vs 0% generic, on 288 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

288
Total Claims
$391K
Total Drug Cost
39
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
466
Total Day Supply
13,653
Brand vs Generic
50% brand / 0% generic
Brand Drug Cost
$378K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
64.7 years
Avg HCC Risk Score
2.91
Gender Split
41% female / 59% male
Age Distribution
<65: 16, 65-74: 17, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Travis Brachtenbach, DO prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Descovy
Emtricitabine/Tenofov Alafenam
21
Biktarvy
Bictegrav/Emtricit/Tenofov Ala
15
Dovato
Dolutegravir Sodium/Lamivudine
15
Tivicay
Dolutegravir Sodium
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Travis Brachtenbach, DO fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Travis Brachtenbach, DO's 288 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Brachtenbach.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Travis Brachtenbach, DO's specialty?
Travis Brachtenbach, DO specializes in Hematology & Oncology Physician and practices in Galveston, Texas. Credentials: DO.
How much does Travis Brachtenbach, DO prescribe under Medicare Part D?
In 2023, Travis Brachtenbach, DO wrote 288 Medicare Part D claims totaling $391K in drug costs for 39 beneficiaries.
Where is Travis Brachtenbach, DO located?
Travis Brachtenbach, DO is located at 301 UNIVERSITY BLVD, Galveston, TX, 77555. Phone: (832) 505-1910.
What is Travis Brachtenbach, DO's NPI number?
Travis Brachtenbach, DO's National Provider Identifier (NPI) is 1043839012, issued on 04/10/2020.
Does Travis Brachtenbach, DO prescribe more brand-name or generic drugs?
Travis Brachtenbach, DO's prescribing is 50% brand-name and 0% generic drugs by claim count, with $378K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Travis Brachtenbach, DO prescribe most often?
Based on 2023 Medicare Part D data, Travis Brachtenbach, DO's most frequently prescribed drugs include Descovy, Biktarvy, Dovato. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Travis Brachtenbach, DO accept Medicare?
Travis Brachtenbach, DO appears in CMS Medicare data with 288 Part D claims and 39 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Travis Brachtenbach, DO's credentials?
Travis Brachtenbach, DO's NPI is 1043839012 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.